Yunhao Capital
VC Fund
Yunhao Capital is an alternative asset management platform focused on the marketplace.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 32%
Last updated:
For AI agents: llms.txt
Industries Yunhao Capital invests in
Stages Yunhao Capital invests in
Countries Yunhao Capital invests in
Investment Focus
Industry
- Manufacturing 4 (18%)
- Semiconductor 2 (9%)
- Audio 1 (5%)
- Energy 1 (5%)
- Medical 1 (5%)
Stage
- Series D 2 (9%)
- Private Equity 2 (9%)
- Seed 1 (5%)
- Series A 1 (5%)
- Series B 1 (5%)
Country
- China 7 (32%)
- United States 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Zhide New Energy
|
Zhide New Energy is a developer of high-capacity silicon anode materials for lithium batteries | $87.8M / Series E / Apr 09, 2026 | |
xMEMS
|
xMEMS designs solutions and applications by integrating smart methodologies for a range of consumer electronics devices. The company was founded in 2018 and is headquartered in Santa Clara, California, United States. | $21M / Series D / Oct 30, 2025 | |
NASN Automotive Electronics
|
NASN Automotive Electronics is committed to providing advanced and complete chassis electronic control products, ADAS and autonomous driving related core technologies for the Chinese automotive market. The main products include NBooster intelligent brake system, brushless electric steering EPS controller and wire control system. It is a scientificand technological innovation enterprise integrating R&D, production and sales. | $68.5M / Series D / Dec 31, 2024 | |
|
xMEMS
|
xMEMS designs solutions and applications by integrating smart methodologies for a range of consumer electronics devices. The company was founded in 2018 and is headquartered in Santa Clara, California, United States. | Series C / Sep 04, 2024 | |
Farber Xintian
|
Farber Xintian CRO company engaged in clinical services of radionuclide drugs. The company focuses on the field of nuclide drugs. Through cooperation with domestic experts in the field of nuclide drugs, the company introduces IP and relies on its own resource advantages to create a VIC model for domestic nuclide drugs. | $13.8M / Series A / May 11, 2024 | |
Newcosemi Technology
|
Newcosemi Technology is a domestically owned IC design company focused on designing and producing mid-to-high-end enterprise-level communication chips and high-definition display circuits using its own core technology. | Series C / Apr 10, 2024 | |
Vivolight
|
Vivolight is a medical research and development company. | $13.9M / Venture - Series Unknown / Mar 05, 2024 | |
Paidian Technology
|
Paidian Technology designs and manufactures smart electric motorcycles. | Venture - Series Unknown / Feb 29, 2024 | |
Jieluo Intelligent
|
Jieluo Intelligent focuses on R&D, design, production and sales of intelligent robot AMR and industry 4.0 systems in the semiconductor field | Private Equity / Jan 01, 2024 | |
Leto Laboratories
|
Leto Laboratories is a manufacturer of protein products. | Private Equity / Jan 01, 2024 | |
| See all 22 investments → | |||
Co-Investors
Sinowisdom
3 deals together
Caitong Capital
2 deals together
Huajin Capital
2 deals together
Innolink Fund
2 deals together
SDIC Fund Management
2 deals together
Zhaoxi Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Yunhao Capital invest in?
Yunhao Capital invests primarily in Manufacturing, Semiconductor and Audio startups, most often at Series D and Private Equity stage. Most of the 22 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Yunhao Capital last invest?
The most recent investment recorded for Yunhao Capital closed in Apr 2026. Shizune tracks 22 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
